Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 2922-2932

  Gallicchio, Marisa A ^a   Bach, Leon A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Diabetes; Glycation; Macropinocytosis; Na+K+ATPase; Nephropathy; TGF

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADVANCED GLYCATION END PRODUCT; AMILORIDE; BOVINE SERUM ALBUMIN; DEXTRAN; EZRIN; NEUTRALIZING ANTIBODY; P21 ACTIVATED KINASE 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL LINE; DIABETIC NEPHROPATHY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; PINOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL;

EID: 84882766895     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.05.024     Document Type: Article

References (70)

1. Vlassara H., Bucala R.S.L. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab. Invest. 1994, 70:138-151.
2. Beisswenger P., Makita Z., Curphey T., Moore L., Jean S., Brinck-Johnsen T., Bucala R., Vlassara H. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease. Diabetes 1995, 44:824-829.
3. Bierhaus A., Hofmann M., Ziegler R., Nawroth P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. Cardiovasc. Res. 1998, 37:586-600.
4. Vlassara H., Striker L., Teichberg S., Fuh H., Li Y., Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11704-11708.
5. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A. Aminoguanidine prevents diabetes-induced arterial wall cross-linking. Science 1986, 1629-1632.
6. Kihara M., Schmelzer J., Poduslo J., Curran G., Nickander K., Low P. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygen free radicals. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:6107-6111.
7. Makita Z., Radoff S., Rayfield E., Yang Z., Skolnik E., Delaney V., Friedman E., Cerami A., Vlassara H. Advanced glycation end products in patients with diabetic nephropathy. N. Engl. J. Med. 1991, 325:836-842.
8. Lieuw A.F.M.L., van Hinsbergh V.W., Teerlink T., Barto R., Twisk J., Stehouwer C.D., Schalkwijk C.G. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol. Dial. Transplant. 2004, 19:631-636.
9. Gallicchio M.A., McRobert E.A., Tikoo A., Cooper M.E., Bach L.A. Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner. J. Am. Soc. Nephrol. 2006, 17:414-421.
10. Gallicchio M.A., Bach L.A. Advanced glycation end products inhibit Na+K+ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma. Biochim. Biophys. Acta 2010, 1803:919-930.
11. Williams S., Devenny J., Bitensky M. Micropinocytic ingestion of glycosylated albumin by isolated microvessels: possible role in pathogenesis of diabetic microangiopathy. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:2393-2397.
12. Villaschi S., Johns L., Cirigliano M., Pietra G. Binding and uptake of native and glycosylated albumin-gold complexes in perfused rat lungs. Microvasc. Res. 1986, 32:190-199.
13. Esposito C., Gerlach H., Brett J., Stern D., Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp. Med. 1989, 170:1387-1407.
14. Dobrogowska D., Lossinsky A., Vorbrodt A. Ultrastructural study of the clearance of intracerebrally infused native and modified albumin-gold complexes. Histol. Histopathol. 1998, 13:647-656.
15. Jaleel A., Halvatsiotis P., Williamson B., Juhasz P., Martin S., Nair K. Identification of amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Diabetes Care 2005, 28:645-652.
16. Lieuw-A-Fa M., van Hinsbergh V., Teerlink T., Barto R., Twisk J., Stehouwer C., Schalkwijk C. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrol. Dial. Transplant. 2004, 19:631-636.
17. Gugliucci A., Bendayan M. Renal fate of circulating advanced glycation end products (AGE): evidence for resorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996, 39:149-160.
18. Ozdemir A.M., Hopfer U., Rosca M.V., Fan X.J., Monnier V.M., Weiss M.F. Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin. Am. J. Nephrol. 2007, 28:14-24.
19. Swanson J., Watts C. Macropinocytosis. Trends Cell Biol. 1995, 5:424-428.
20. Haigler H., McKanna J., Cohen S. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J. Cell Biol. 1979, 83:82-90.
21. Donaldson J. Multiple roles for Arf6: sorting, structuring and signaling at the plasma membrane. J. Biol. Chem. 2003, 278:41573-41576.
22. Honda A., Nogami M., Yokozeki T., Yamazaki M., Nakamura H., Watanabe H., Kawamoto K., Nakayama K., Morris A., Frohman M., Kanaho Y. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 1999, 99:521-532.
23. Brown F., Rozelle A., Yin H., Balla T., Donaldson J. Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol. 2001, 154:1007-1017.
24. Amyere M., Payrastre B., Kruase P., Smissen A., Veithen A., Courtroy P. Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol. Biol. Cell 2000, 11:3453-3467.
25. Botelho R., Teruel M., Dierckman R., Anderson R., Wells A., York J., Meyer T., Grinstein S. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell Biol. 2000, 151:1353-1368.
26. Dharamawardhane S., Sanders L., Martin S., Daniels R., Bokoch G. Localization of p21-activated kinase 1 (Pak1) to pinocytic vesicles and cortical actin structures in stimulated cells. J. Cell Biol. 1997, 138:1265-1278.
27. Oldfield M., Bach L., Forbes J., Nikolic-Paterson D., McRobert E., Thallas V., Atkins R., Osicka T., Jerums G., Cooper M. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J. Clin. Invest. 2001, 108:1853-1863.
28. Westwood M.E., Argirov O.K., Abordo E.A., Thornalley P.J. Methylglyoxal-modified arginine residues-a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells. Biochim. Biophys. Acta 1997, 1356:84-94.
29. Hull R.N., Cherry W.R., Weaver G.W. The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro 1976, 12:670-677.
30. Ryan M.J., Johnson G., Kirk J., Fuerstenberg S.M., Zager R.A., Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994, 45:48-57.
31. Patil S., Bunderson M., Wilham J., Black S.M. Important role for Rac1 in regulating reactive oxygen species generation and pulmonary arterial smooth muscle cell growth. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L1314-L1322.
32. Desire L., Bourdin J., Loiseau N., Peillon H., Picard V., De Oliveira C., Bachelot F., Leblond B., Taverne T., Beausoleil E., Lacombe S., Drouin D., Schweighoffer F. RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J. Biol. Chem. 2005, 280:37516-37525.
33. Salvador L., Mukherjee S., Kahn R., Lamm M., Fazleabas A., Maizels E., Bader M., Hamm H., Rasenick M., Casanova J., Hunzicker-Dunn M. Activation of the luteinizing hormone/choriogonadotropin hormone receptor promotes ADP ribosylation factor 6 activation in porcine ovarian follicular membranes. J. Biol. Chem. 2001, 276:33773-33781.
34. Kalin S., Amstutz B., Gastaldelli M., Wolfrum N., Boucke K., Havenga M., DiGennaro F., Liska N., Hemmi S., Greber U.F. Macropinocytotic uptake and infection of human epithelial cells with species B2 adenovirus type 35. J. Virol. 2010, 84:5336-5350.
35. Koivusalo M., Welch C., Hayashi H., Scott C.C., Kim M., Alexander T., Touret N., Hahn K.M., Grinstein S. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J. Cell Biol. 2010, 188:547-563.
36. Collison K. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J. Leukoc. Biol. 2002, 71:433-444.
37. Mao Y.S., Yamaga M., Zhu X., Wei Y., Sun H.Q., Wang J., Yun M., Wang Y., Di Paolo G., Bennett M., Mellman I., Abrams C.S., De Camilli P., Lu C.Y., Yin H.L. Essential and unique roles of PIP5K-gamma and -alpha in Fcgamma receptor-mediated phagocytosis. J. Cell Biol. 2009, 184:281-296.
38. Swanson J.A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol. 2008, 9:639-649.
39. D'Angelo R., Aresta S., Blangy A., Del Maestro L., Louvard D., Arpin M. Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells. Mol. Biol. Cell 2007, 18:4780-4793.
40. Balana M., Nierdergang F., Subtil A., Alcover A., Chavrier P., Dautry-Varsat A. ARF6 GTPase controls bacterial invasion by actin remodelling. J. Cell Sci. 2005, 118:2201-2210.
41. Hills C.E., Squires P.E. The role of TGF-beta and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011, 22:131-139.
42. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M. Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubule cells. Kidney Int. 2003, 63:464-473.
43. Aikawa Y., Martin T.F. ADP-ribosylation factor 6 regulation of phosphatidylinositol-4,5-bisphosphate synthesis, endocytosis, and exocytosis. Methods Enzymol. 2005, 404:422-431.
44. Guthrow C., Day J., Thorpe S. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:4258-4261.
45. Cohen M., Ziyadeh F., Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J. Lab. Clin. Med. 2006, 147:211-219.
46. Asano M., Fujita Y., Ueda Y., Suzuki D., Miyata T., Sakai H., Saito A. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product. Nephron 2002, 91:688-694.
47. Miyata T., Ueda Y., Horie K., Nangaku M., Tanaka S., van Ypersele de Strihou C., Kurokawa K. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int. 1998, 53:416-422.
48. Suzuki D., Miyata T., Saotome N., Horie K., Inagi R., Yasuda Y., Uchida K., Izuhara Y., Yagame M., Sakai H., Kurokawa K. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 1999, 10:822-832.
49. Ishibashi T., Tanaka K., Taniguchi Y. Disruption of blood-retinal barrier in experimental diabetic rats: an electron microscopic study. Exp. Eye Res. 1980, 30:401-410.
50. Guest C.B., Chakour K.S., Freund G.G. Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunol. 2008, 9:42-50.
51. D'Souza C., Li G., Colombo M., Stahl P. A regulatory role for ARF6 in receptor-mediated endocytosis. Science 1995, 267:1175-1178.
52. Radhakrishna H., Donaldson J. ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J. Cell Biol. 1997, 139:49-61.
53. Padival A., Hawkins K., Huang C. High glucose-induced membrane translocation of PKC beta1 is associated with arf6 in glomerular mesangial cells. Mol. Cell. Biochem. 2004, 258:129-135.
54. Fleming I.N., Batty I.H., Prescott A.R., Gray A., Kular G.S., Stewart H., Downes C.P. Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1. Biochem. J. 2004, 382:857-865.
55. Crompton A.M., Foley L.H., Wood A., Roscoe W., Stokoe D., McCormick F., Symons M., Bollag G. Regulation of Tiam1 nucleotide exchange activity by pleckstrin domain binding ligands. J. Biol. Chem. 2000, 275:25751-25759.
56. Heo W.D., Inoue T., Park W.S., Kim M.L., Park B.O., Wandless T.J., Meyer T. PI(3,4,5)P3 and PI(4,5)P2 lipids target proteins with polybasic clusters to the plasma membrane. Science 2006, 314:1458-1461.
57. Otsuki Y., Tanaka M., Yoshii S., Kawazoe N., Nakaya K., Sugimura H. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. PNAS 2001, 98:4385-4390.
58. Ridley A., Paterson H., Johnston C., Diekman D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
59. Ahram M., Sameni M., Qiu R.-G., Linebaugh B., Kirn D., Sloane B. Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix. Exp. Cell Res. 2000, 260:292-303.
60. Lodge R., Descoteaux A. Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur. J. Immunol. 2006, 36:2735-2744.
61. Le Cabec V., Carreno S., Moisand A., Bordier C., Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J. Immunol. 2002, 169:2003-2009.
62. Le Cabec V., Cols C., Maridonneau-Parini I. Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect. Immun. 2000, 68:4736-4745.
63. Radhakrishna H., Al-Awar O., Khachikian Z., Donaldson J. ARF6 requirement for rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. J. Cell Sci. 1999, 112:855-866.
64. Zhang Q., Calafat J., Janssen H., Greenberg S. ARF6 is required for growth factor-and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. Mol. Biol. Cell 1999, 19:8158-8168.
65. Boshans R., Szanto S., van Aelst L., D'Souza-Schorey C. ADP-ribosylation factor 6 regulates actin cytoskeleton remodeling in coordination with Rac1 and RhoA. Mol. Biol. Cell 2000, 20:3685-3694.
66. Tang S.C., Leung J.C., Lai K.N. Diabetic tubulopathy: an emerging entity. Contrib. Nephrol. 2011, 170:124-134.
67. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 2002, 109:41-50.
68. Xia P., Kramer R.M., King G.L. Identification of the mechanism for the inhibition of Na+, K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J. Clin. Invest. 1995, 96:733-740.
69. +-ATPase and diabetes. Exp. Diabesity Res. 2004, 5:37-50.
70. Rajasekaran S.A., Huynh T.P., Wolle D.G., Espineda C.E., Inge L.J., Skay A., Lassman C., Nicholas S.B., Harper J.F., Reeves A.E., Ahmed M.M., Leatherman J.M., Mullin J.M., Rajasekaran A.K. Na, K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol. Cancer Ther. 2010, 9:1515-1524.